Drug Overdose Deaths Decline in the U.S.

New provisional data from the CDC’s National Vital Statistics System (NVSS) indicates a significant decline in drug overdose deaths in the United States. Predictions for the 12 months ending in September 2024 suggest a nearly 24% decrease compared to the previous year. This represents a continued downward trend, with approximately 87,000 drug overdose deaths occurring between October 2023 and September 2024, down from around 114,000 the year prior. This is the lowest number of overdose deaths recorded in any 12-month period since June 2020.

A Historic Drop in Overdose Fatalities

“It is unprecedented to see predicted overdose deaths drop by more than 27,000 over a single year,” stated Allison Arwady, MD, MPH, Director of the CDC’s National Center for Injury Prevention and Control. “That’s more than 70 lives saved every day.” The CDC attributes this progress to public health investments, improved data and laboratory systems for overdose response, and strengthened partnerships with public safety colleagues across all states.

Continued Challenges and Disparities

Despite the encouraging national decline, overdose remains the leading cause of death for Americans aged 18-44, underscoring the demand for sustained prevention efforts. While 45 states have reported declines in overdose deaths, five states – Alaska, Montana, Nevada, South Dakota, and Utah – have seen increases, highlighting the importance of localized data and tailored responses. Provisional data also indicates decreases in nonfatal overdoses, as measured by emergency department visits, and in self-reported youth substance use.

Factors Contributing to the Decline

Several factors are believed to be contributing to the reduction in overdose deaths:

• Widespread Naloxone Distribution: Increased access to and distribution of naloxone, a life-saving medication that can reverse opioid overdoses.
• Improved Access to Treatment: Better access to evidence-based treatment for substance use disorders.
• Shifts in the Drug Supply: Changes in the composition of the illegal drug supply.
• Resumption of Prevention Efforts: A renewed focus on prevention and response initiatives following disruptions caused by the COVID-19 pandemic.
• Investments in Prevention Programs: Continued funding for programs like the CDC’s Overdose Data to Action (OD2A) program.

CDC’s Overdose Data to Action (OD2A) Program

The CDC’s OD2A program provides robust data through its fatal (SUDORS) and nonfatal (DOSE) overdose data systems. Currently, 49 states and 41 local health departments receive OD2A funding to collect, improve, and utilize data in their communities to implement life-saving activities. This program supports comprehensive laboratory testing to identify emerging substances involved in overdoses and track geographic shifts in the illegal drug supply. State and local public health departments collaborate with CDC experts to use this data to inform targeted overdose prevention efforts.

The CDC also funds the Overdose Response Strategy, a public health-public safety data collaboration in every state, enabling law enforcement officials to use data to better understand and intercept illegal drugs.

Looking Ahead

While the current trend is positive, continued investment in prevention is crucial to further reduce overdose deaths. Expanding access to evidence-based treatment for substance use disorders, including medications for opioid use disorder like buprenorphine and methadone, is essential. Building community-driven interventions and promoting education and early intervention to prevent substance use disorders are also vital steps.

For more information on CDC’s overdose prevention efforts and data, visit: What CDC is Doing | Overdose Prevention | CDC